2007's most comprehensive QT & Safety Pharmacology Strategy Congress takes place in just under two weeks!

Posted:
11
October 2007

The pre-conference workshop will be hosted by Richmond Pharmacology; the leading Trial Centre and ECG Core Lab for conducting QTc studies. The workshop will address 'Key Issues and Best Practice in Conducting a Definitive Thorough QTc Study'.Included in the line up of speakers will be Prof. A. J. Camm, Chairman of the Department of Cardiovascular Sciences and the Division of Cardiological Sciences, St George's Hospital, UK. This offers you the unique opportunity to discuss the latest developments in the design and conduct of QTc studies. Please click the following link to view the agenda for the meeting.As hosts of the QTc Workshop we are pleased to offer the Workshop at a discounted rate to our clients. Alternatively, we are able to also offer both the workshop and main conference for the reduced price of £250. For further information contact Charlotte Vowden at c.vowden@richmondpharmacology.com.

Latest news

Upcoming Event

On Helix, Transforming new medicine discovery

13-14 July 2020
Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.
View event

COVID-19 – External Monitoring Guidelines

July 1, 2020
Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing Public Health England guidance.
Read more

First transdermal patch to treat schizophrenia hits market

March 18, 2020
The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia developed by Hisamitsu Pharmaceutical Co following successful
Read more

Statement: COVID-19

March 23, 2020
Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are evaluating what activity can continue, what precautions need to be put in place and what needs to be suspended.
Read more